Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,056.80
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
102.00
(
0.79%
)
Bitcoin
77,633.05
(
-0.82%
)
News Focus
News Focus
Post# of 246413
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3160
Posts 967883
Boards Moderated 152
Alias Born 09/04/2000

mick

Member Level

Re: mick post# 222624

Saturday, 09/19/2020 10:29:51 PM

Saturday, September 19, 2020 10:29:51 PM

Post# of 246413
$MRNA TARGET $95
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
2020 Sep 18, 12:35pm | 4 min read
Coronavirus vaccine developer Moderna Inc (NASDAQ: MRNA) held a virtual R&D event Thursday, showcasing its portfolio and key therapeutic areas. The Moderna Analysts: Chardan analyst Geulah Livshits has a Buy rating on Moderna with a $95 price target. SVB Leerink analyst Mani...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today